Skip to nav Skip to content
  • Overview

    Cancer Focus:
    Osteosarcoma, Sarcoma

    Dr. Bui is a Senior Member in the Department of Pathology at Moffitt Cancer Center & Research Institute. She serves as the Scientific Director of the Analytic Microscopy Core. She is also a Professor and the Director of the Cytopathology Fellowship at the University of South Florida (USF) Morsani College of Medicine. Providing the best possible patient care is the number one mission for Dr. Bui. Her expertise includes bone and soft tissue pathology, cytopathology, biomarker testing, digital pathology, and AI. She is a patient-centered pathologist who combines research, education, advocacy, and service for better patient care and received the 2019 College of American Pathologists (CAP) Distinguished Patient Care Award. Dr. Bui is the study Pathologist for multiple research grants. She has published over 200 peer-reviewed articles, 30 book chapters and 3 books, including The Atlas of Bone and Soft Tissue Pathology, The Healing Art of Pathology, and the Modern Techniques in Cytopathology. She is an inventor and has received 3 patents in Digital Pathology and cancer diagnostics. Dr. Bui is an award-winning educator and mentor. She has frequently lectured both nationally and internationally, including keynote presentations. She is the editorial board member of multiple journals.  Dr. Bui values the service to professional societies and views it as an important mechanism to influence policies and standards to help improve the quality of patient care in a broader sense. She serves on committees organizing national meetings on Pathology education. She is a panel member of the National Comprehensive Cancer Network (NCCN) Soft Tissue Sarcoma Guidelines. Her leadership experience includes but is not limited to being the President of the Digital Pathology Association (2019), the President of the Medical Staff of Moffitt Cancer Center (2018-2020), the Chair of the Publications Committee and the Editorial Board of CAP Today (2018-2021), Chair of the expert panel of HER2 quantitative image analysis of breast cancer guidelines of CAP (2016-2019), and the current Chair of the Digital and Computational Pathology committee of the CAP. Dr. Bui is passionate about advocating the critical role of Pathology and Laboratory Medicine in precision medicine. She has been interviewed and featured in journals/magazines, podcasts, and a documentary film.

    Education & Training


    • University of Florida Health Science Center - Pathology
    • University of Florida Health Science Center - Cytopathology


    • University of Florida Health Science Center - Department of Pathology

    Medical School:

    • Capital Institute of Medicine, Beijing, China - MD
  • Publications

    • Tozbikian G, Krishnamurthy S, Bui MM, Feldman M, Hicks DG, Jaffer S, Khoury T, Wei S, Wen H, Pohlmann P. Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression. Arch Pathol Lab Med. 2024 Feb.148(2):242-255. Pubmedid: 37014972.
    • Miroshnychenko D, Miti T, Kumar P, Miller A, Laurie M, Giraldo N, Bui MM, Altrock PM, Basanta D, Marusyk A. Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy Cycles. Cancer Res. 2023 Nov.83(22):3681-3692. Pubmedid: 37791818. Pmcid: PMC10646478.
    • Waqas A, Bui MM, Glassy EF, El Naqa I, Borkowski P, Borkowski AA, Rasool G. Revolutionizing Digital Pathology With the Power of Generative Artificial Intelligence and Foundation Models. Lab Invest. 2023 Nov.103(11):100255. Pubmedid: 37757969.
    • Beauchamp NJ, Bryan RN, Bui MM, Krestin GP, McGinty GB, Meltzer CC, Neumaier M. Integrative diagnostics: the time is now-a report from the International Society for Strategic Studies in Radiology. Insights Imaging. 2023 Mar.14(1):54. Pubmedid: 36995467. Pmcid: PMC10063732.
    • Cortes-Ciriano I, Steele CD, Piculell K, Al-Ibraheemi A, Eulo V, Bui MM, Chatzipli A, Dickson BC, Borcherding DC, Feber A, Galor A, Hart J, Jones KB, Jordan JT, Kim RH, Lindsay D, Miller C, Nishida Y, Proszek PZ, Serrano J, Sundby RT, Szymanski JJ, Ullrich NJ, Viskochil D, Wang X, Snuderl M, Park PJ, Flanagan AM, Hirbe AC, Pillay N, Miller DT. Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. Cancer Discov. 2023 Mar.13(3):654-671. Pubmedid: 36598417. Pmcid: PMC9983734.
    • Palm RF, Liveringhouse CL, Gonzalez RJ, Bui MM, Binitie O, Yang GQ, Naghavi AO. Effect of Favorable Pathologic Response After Neoadjuvant Radiation Therapy Alone in Soft-tissue Sarcoma. Adv Radiat Oncol. 2023 Jan.8(1):101086. Pubmedid: 36483058. Pmcid: PMC9723307.
    • Miroshnychenko D, Miti T, Miller A, Kumar P, Laurie M, Bui MM, Altrock PM, Basanta D, Marusyk A. Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cycles. bioRxiv. 2023 Feb. Pubmedid: 36798328. Pmcid: PMC9934626.
    • Hanna MG, Olson NH, Zarella M, Dash RC, Herrmann MD, Furtado LV, Stram MN, Raciti PM, Hassell L, Mays A, Pantanowitz L, Sirintrapun JS, Krishnamurthy S, Parwani A, Lujan G, Evans A, Glassy EF, Bui MM, Singh R, Souers RJ, de Baca ME, Seheult JN. Recommendations for Performance Evaluation of Machine Learning in Pathology: A Concept Paper From the College of American Pathologists. Arch Pathol Lab Med. 2023 Dec. Pubmedid: 38041522.
    • Kim D, Sundling KE, Virk R, Thrall MJ, Alperstein S, Bui MM, Chen-Yost H, Donnelly AD, Lin O, Liu X, Madrigal E, Michelow P, Schmitt FC, Vielh PR, Zakowski MF, Parwani AV, Jenkins E, Siddiqui MT, Pantanowitz L, Li Z. Digital cytology part 1: digital cytology implementation for practice: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force. J Am Soc Cytopathol. 2023 Dec. Pubmedid: 38158316.
    • Kim D, Sundling KE, Virk R, Thrall MJ, Alperstein S, Bui MM, Chen-Yost H, Donnelly AD, Lin O, Liu X, Madrigal E, Michelow P, Schmitt FC, Vielh PR, Zakowski MF, Parwani AV, Jenkins E, Siddiqui MT, Pantanowitz L, Li Z. Digital cytology part 2: artificial intelligence in cytology: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force. J Am Soc Cytopathol. 2023 Dec. Pubmedid: 38158317.
    • Zota V, Siegal GP, Kelly D, Bridge JA, Berglund A, Bui K, Khalil F, R Reed D, Altiok S, Magliocco A, Bui MM. Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma. Fetal Pediatr Pathol. 2023 Apr.42(2):241-252. Pubmedid: 36062956.
    • Hassell LA, Absar SF, Chauhan C, Dintzis S, Farver CF, Fathima S, Glassy EF, Goldstein JA, Gullapalli R, Ho J, Koch LK, Madory JE, Mirza KM, Nguyen PN, Pantanowitz L, Parwani A, Rojansky R, Seifert RP, Singh R, ElGabry EA, Bui M. Pathology Education Powered by Virtual and Digital Transformation: Now and the Future. Arch Pathol Lab Med. 2023 Apr.147(4):474-491. Pubmedid: 35878400.
    • Beauchamp NJ, Bryan RN, Bui MM, Krestin GP, McGinty GB, Meltzer CC, Neumaier M. Integrative Diagnostics: The Time Is Now-A Report From the International Society for Strategic Studies in Radiology. J Am Coll Radiol. 2023 Apr.20(4):455-466. Pubmedid: 36565973.
    • Miao R, Bui MM, Walko C, Mullinax JE, Brohl AS. A Malignant Glomus Tumor of the Liver Harboring MIR143-NOTCH2 Rearrangement: From Diagnosis to Management. Cureus. 2022 Oct.14(10):e30718. Pubmedid: 36439569. Pmcid: PMC9696860.
    • von Mehren M, Kane JM, Riedel RF, Sicklick JK, Pollack SM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ, Holder A, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Mesko NW, Meyer C, Pappo AS, Parkes AM, Petersen IA, Poppe M, Schuetze S, Shabason J, Spraker MB, Zimel M, Bergman MA, Sundar H, Hang LE. NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022. J Natl Compr Canc Ne. 2022 Nov.20(11):1204-1214. Pubmedid: 36351335.
    • Pantanowitz L, Bui MM, Chauhan C, ElGabry E, Hassell L, Li Z, Parwani AV, Salama ME, Sebastian MM, Tulman D, Vepa S, Becich MJ. Rules of engagement: Promoting academic-industry partnership in the era of digital pathology and artificial intelligence. Acad Pathol. 2022 May.9(1):100026. Pubmedid: 35669406. Pmcid: PMC9163695.
    • Pillai S, Mahmud I, Mahar R, Griffith C, Langsen M, Nguyen J, Wojtkowiak JW, Swietach P, Gatenby RA, Bui MM, Merritt ME, McDonald P, Garrett TJ, Gillies RJ. Lipogenesis mediated by OGR1 regulates metabolic adaptation to acid stress in cancer cells via autophagy. Cell Rep. 2022 May.39(6):110796. Pubmedid: 35545051. Pmcid: PMC9137419.
    • Russell S, Xu L, Kam Y, Abrahams D, Ordway B, Lopez AS, Bui MM, Johnson J, Epstein T, Ruiz E, Lloyd MC, Swietach P, Verduzco D, Wojtkowiak J, Gillies RJ. Proton export upregulates aerobic glycolysis. BMC Biol. 2022 Jul.20(1):163. Pubmedid: 35840963. Pmcid: PMC9287933.
    • von Mehren M, Kane JM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ, Holder A, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Mesko NW, Meyer C, Pappo AS, Parkes AM, Petersen IA, Pollack SM, Poppe M, Riedel RF, Schuetze S, Shabason J, Sicklick JK, Spraker MB, Zimel M, Hang LE, Sundar H, Bergman MA. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Ne. 2022 Jul.20(7):815-833. Pubmedid: 35830886.
    • Fusco MJ, Knepper TC, Balliu J, Del Cueto A, Laborde JM, Hooda SM, Brohl AS, Bui MM, Hicks JK. Evaluation of Targeted Next-Generation Sequencing for the Management of Patients Diagnosed with a Cancer of Unknown Primary. Oncologist. 2022 Feb.27(1):e9-e17. Pubmedid: 35305098. Pmcid: PMC8842368.
    • Berkowitz SJ, Kwan D, Cornish TC, Silver EL, Thullner KS, Aisen A, Bui MM, Clark SD, Clunie DA, Eid M, Hartman DJ, Ho K, Leontiev A, Luviano DM, O'Toole PE, Parwani AV, Pereira NS, Rotemberg V, Vining DJ, Gaskin CM, Roth CJ, Folio LR. Interactive Multimedia Reporting Technical Considerations: HIMSS-SIIM Collaborative White Paper. J Digit Imaging. 2022 Aug.35(4):817-833. Pubmedid: 35962150. Pmcid: PMC9485305.
    • Zhao X, Boothe P, Hussnain Naqvi SM, Henderson-Jackson E, Mela N, Centeno BA, Tandon A, Bui MM. Assessing ROSE for adequacy of EBUS-TBNA compared with a direct-to-cell block approach as a response to the COVID-19 pandemic. J Am Soc Cytopathol. 2022 Aug.11(6):368-374. Pubmedid: 35995701. Pmcid: PMC9339095.
    • Yang G, Yuan Z, Ahmed K, Welsh EA, Fulp WJ, Gonzalez RJ, Mullinax JE, Letson D, Bui M, Harrison LB, Scott JG, Torres-Roca JF, Naghavi AO. Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization. Transl Oncol. 2021 Oct.14(10):101165. Pubmedid: 34246048. Pmcid: PMC8274330.
    • Kearney SJ, Lowe A, Lennerz JK, Parwani A, Bui MM, Wack K, Giannini G, Abels E. Bridging the Gap: The Critical Role of Regulatory Affairs and Clinical Affairs in the Total Product Life Cycle of Pathology Imaging Devices and Software. Front Med (Lausanne). 2021 Nov.8:765385. Pubmedid: 34869473. Pmcid: PMC8635712.
    • Bui MM, Zhang LLJ, Wang HP. Updates and Diagnostic Challenges in Surgical Pathology and Cytopathology. Arch Pathol Lab Med. 2021 Nov.145(11):1355-1357. Pubmedid: 34673909.
    • Miroshnychenko D, Baratchart E, Ferrall-Fairbanks MC, Velde RV, Laurie MA, Bui MM, Tan AC, Altrock PM, Basanta D, Marusyk A. Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populations. Nat Ecol Evol. 2021 Mar.5(3):379-391. Pubmedid: 33462489.
    • Jardim-Perassi BV, Mu W, Huang S, Tomaszewski MR, Poleszczuk J, Abdalah MA, Budzevich MM, Dominguez-Viqueira W, Reed DR, Bui MM, Johnson JO, Martinez GV, Gillies RJ. Deep-learning and MR images to target hypoxic habitats with evofosfamide in preclinical models of sarcoma. Theranostics. 2021 Mar.11(11):5313-5329. Pubmedid: 33859749. Pmcid: PMC8039958.
    • Robinson LA, Babacan NA, Tanvetyanon T, Henderson-Jackson E, Bui MM, Druta M. Results of treating primary pulmonary sarcomas and pulmonary carcinosarcomas. J Thorac Cardiovasc Surg. 2021 Jul.162(1):274-284. Pubmedid: 32711968.
    • Ibrahim-Hashim A, Luddy K, Abrahams D, Enriquez-Navas P, Damgaci S, Yao J, Chen T, Bui MM, Gillies RJ, O'Farrelly C, Richards CL, Brown JS, Gatenby RA. Artificial selection for host resistance to tumour growth and subsequent cancer cell adaptations: an evolutionary arms race. Brit J Cancer. 2021 Jan.124(2):455-465. Pubmedid: 33024265. Pmcid: PMC7852689.
    • Gong L, Bui MM, Zhang W, Sun X, Zhang M, Yi D. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors. Histol Histopathol. 2021 Jan.36(1):61-68. Pubmedid: 33021329.
    • Liu W, Chan CM, Gong L, Bui MM, Han G, Letson GD, Yang Y, Niu X. Malignancy in giant cell tumor of bone in the extremities. J Bone Oncol. 2021 Feb.26:100334. Pubmedid: 33251099. Pmcid: PMC7680773.
    • Lara H, Li Z, Abels E, Aeffner F, Bui MM, ElGabry EA, Kozlowski C, Montalto MC, Parwani AV, Zarella MD, Bowman D, Rimm D, Pantanowitz L. Quantitative Image Analysis for Tissue Biomarker Use: A White Paper From the Digital Pathology Association. Appl Immunohistochem Mol Morphol. 2021 Aug.29(7):479-493. Pubmedid: 33734106. Pmcid: PMC8354563.
    • Lujan G, Quigley JC, Hartman D, Parwani A, Roehmholdt B, Meter BV, Ardon O, Hanna MG, Kelly D, Sowards C, Montalto M, Bui M, Zarella MD, LaRosa V, Slootweg G, Retamero JA, Lloyd MC, Madory J, Bowman D. Dissecting the Business Case for Adoption and Implementation of Digital Pathology: A White Paper from the Digital Pathology Association. J Pathol Inform. 2021 Apr.12:17. Pubmedid: 34221633. Pmcid: PMC8240548.
    • Nelson J, Mousa MS, Diaz J, Bui MM, Caracciolo JT. Unusual Presentation of Widely Metastatic Extraskeletal Osteosarcoma: Case Report. J Radiol Case Rep. 2021 Apr.15(4):7-16. Pubmedid: 34276871. Pmcid: PMC8253146.
    • Cory P, Qiong G, Yun G, Liron P, Evita HJ, Daryoush SV, Nancy M, Daniel P, Nazeel A, Atif A, Marilyn B. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases. J Am Soc Cytopathol. 2020 Nov.9(6):513-519. Pubmedid: 32624384.
    • Gonzalez E, Bui M, Ahmed AA. IGF1R immunohistochemistry in Ewing's sarcoma as predictor of response to targeted therapy. Int J Health Sci (Qassim). 2020 Jul.14(4):17-21. Pubmedid: 32694968. Pmcid: PMC7346972.
    • von Mehren M, Kane JM, Bui MM, Choy E, Connelly M, Dry S, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Meyer C, Pappo AS, Parkes AM, Paz IB, Petersen IA, Poppe M, Riedel RF, Rubin B, Schuetze S, Shabason J, Sicklick JK, Spraker MB, Zimel M, Bergman MA, George GV. NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021. J Natl Compr Canc Ne. 2020 Dec.18(12):1604-1612. Pubmedid: 33285515.
    • Miller DT, Cortés-Ciriano I, Pillay N, Hirbe AC, Snuderl M, Bui MM, Piculell K, Al-Ibraheemi A, Dickson BC, Hart J, Jones K, Jordan JT, Kim RH, Lindsay D, Nishida Y, Ullrich NJ, Wang X, Park PJ, Flanagan AM. Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. Genes (Basel). 2020 Apr.11(4). Pubmedid: 32252413. Pmcid: PMC7231181.
    • Li L, Bui MM, Zhang M, Sun X, Han G, Zhang T, Huang X, Ding Y. Validation of Fluorescence in situ Hybridization Testing of USP6 Gene Rearrangement for Diagnosis of Primary Aneurysmal Bone Cyst. Ann Clin Lab Sci. 2019 Sep.49(5):590-597. Pubmedid: 31611201.
    • Bui MM, Riben MW, Allison KH, Chlipala E, Colasacco C, Kahn AG, Lacchetti C, Madabhushi A, Pantanowitz L, Salama ME, Stewart RL, Thomas NE, Tomaszewski JE, Hammond ME. Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists. Arch Pathol Lab Med. 2019 Oct.143(10):1180-1195. Pubmedid: 30645156. Pmcid: PMC6629520.
    • Bridge JA, Sumegi J, Druta M, Bui MM, Henderson-Jackson E, Linos K, Baker M, Walko CM, Millis S, Brohl AS. Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma. Mod Pathol. 2019 Nov.32(11):1593-1604. Pubmedid: 31189996.
    • Abels E, Pantanowitz L, Aeffner F, Zarella MD, Vd Laak J, Bui MM, Vemuri VNP, Parwani AV, Gibbs J, Agosto-Arroyo E, Beck AH, Kozlowski C. Computational pathology definitions, best practices, and recommendations for regulatory guidance: a white paper from the Digital Pathology Association. J Pathol. 2019 Nov.249(3):286-294. Pubmedid: 31355445. Pmcid: PMC6852275.
    • Sephien A, Mousa MS, Bui MM, Kedar R, Thomas K. Leiomyosarcoma of the Inferior Vena Cava with Hepatic and Pulmonary Metastases: Case Report. J Radiol Case Rep. 2019 May.13(5):30-40. Pubmedid: 31558957. Pmcid: PMC6742446.
    • Wells AE, Mallen AM, Bui MM, Reed DR, Apte SM. NTRK-1 fusion in endocervical fibroblastic malignant peripheral nerve sheath tumor marking eligibility for larotrectinib therapy: A case report. Gynecol Oncol Rep. 2019 May.28:141-144. Pubmedid: 31080864. Pmcid: PMC6506462.
    • Ding Y, Bui MM, Wang Q, Sun X, Zhang M, Niu X, Tian W. ADAM10 Is a Potential Novel Prognostic Biomarker for Sacral Chordoma. Ann Clin Lab Sci. 2019 May.49(3):309-316. Pubmedid: 31308029.
    • Perkins AR, Macaulay RJB, Bui MM, Bridge JA, Etame AB. A Frontal Dural-Based Lesion in a 63-Year Old Male. Brain Pathol. 2019 Mar.29(2):301-302. Pubmedid: 30821029. Pmcid: PMC8028399.
    • Aeffner F, Zarella MD, Buchbinder N, Bui MM, Goodman MR, Hartman DJ, Lujan GM, Molani MA, Parwani AV, Lillard K, Turner OC, Vemuri VNP, Yuil-Valdes AG, Bowman D. Introduction to Digital Image Analysis in Whole-slide Imaging: A White Paper from the Digital Pathology Association. J Pathol Inform. 2019 Mar.10:9. Pubmedid: 30984469. Pmcid: PMC6437786.
    • Wu H, Bui MM, Zhou L, Li D, Zhang H, Zhong D. Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review. Mod Pathol. 2019 Feb.32(2):189-204. Pubmedid: 30206408.
    • Zarella MD, Bowman D, Aeffner F, Farahani N, Xthona A, Absar SF, Parwani A, Bui M, Hartman DJ. A Practical Guide to Whole Slide Imaging: A White Paper From the Digital Pathology Association. Arch Pathol Lab Med. 2019 Feb.143(2):222-234. Pubmedid: 30307746.
    • Al-Husseinawi E, Bui MM, Ahmed AA. Grb2-associated binding protein-1 as a biomarker in bone and soft tissue sarcomas. Pathology. 2019 Aug.51(6):610-614. Pubmedid: 31443923.
    • Jardim-Perassi BV, Huang S, Dominguez-Viqueira W, Poleszczuk J, Budzevich MM, Abdalah MA, Pillai SR, Ruiz E, Bui MM, Zuccari DAPC, Gillies RJ, Martinez GV. Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models. Cancer Res. 2019 Aug.79(15):3952-3964. Pubmedid: 31186232. Pmcid: PMC6677627.
    • Boddu S, Walko CM, Bienasz S, Bui MM, Henderson-Jackson E, Naghavi AO, Mullinax JE, Joyce DM, Binitie O, Letson GD, Gonzalez RJ, Reed DR, Druta M, Brohl AS. Clinical Utility of Genomic Profiling in the Treatment of Advanced Sarcomas: A Single-Center Experience. JCO Precis Oncol. 2018 Nov.2:1-8. Pubmedid: 35135155.
    • Evans AJ, Bauer TW, Bui MM, Cornish TC, Duncan H, Glassy EF, Hipp J, McGee RS, Murphy D, Myers C, O'Neill DG, Parwani AV, Rampy BA, Salama ME, Pantanowitz L. US Food and Drug Administration Approval of Whole Slide Imaging for Primary Diagnosis: A Key Milestone Is Reached and New Questions Are Raised. Arch Pathol Lab Med. 2018 Nov.142(11):1383-1387. Pubmedid: 29708429.
    • von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Keedy V, Kim E, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C, Morris ZS, O'Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Ruo B, Schuetze S, Tap WD, Wayne JD, Bergman MA, Scavone JL. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Ne. 2018 May.16(5):536-563. Pubmedid: 29752328.
    • Soliman H, Khambati F, Han HS, Ismail-Khan R, Bui MM, Sullivan DM, Antonia S. A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer. Oncotarget. 2018 Feb.9(11):10110-10117. Pubmedid: 29515795. Pmcid: PMC5839376.
    • Fontenot PB, Jesurajan J, Bui M, Reed D, Binitie O. Recurrent Aneurysmal Bone Cyst of the Distal Fibula Treated with Denosumab and Curettage. Case Rep Oncol Med. 2018 Dec.2018:1574343. Pubmedid: 30631617. Pmcid: PMC6304848.
    • Jeong D, Bui M, Peterson D, Montilla-Soler J, Gage KL. FDG avid breast cancer bone metastases silent on CT and scintigraphy: a case report with radiologic-pathologic correlation. Acta Radiol Open. 2017 Oct.6(10):2058460117734243. Pubmedid: 29051834. Pmcid: PMC5638166.
    • Ibrahim-Hashim A, Robertson-Tessi M, Enrizues-Navas P, Damaghi M, Balagurunathan Y, Wojtkowiak JW, Russell S, Yoonseok K, Lloyd MC, Bui MM, Brown JS, Anderson AR, Gillies RJ, Gatenby RA. Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution. Cancer Res. 2017 May.77(9):2242-2254. Pubmedid: 28249898. Pmcid: PMC6005351.
    • Naghavi AO, Gonzalez RJ, Scott JG, Mullinax JE, Abuodeh YA, Kim Y, Binitie O, Ahmed KA, Bui MM, Saini AS, Zager JS, Biagioli MC, Letson D, Harrison LB, Fernandez DC. Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma. Brachytherapy. 2017 Jul.15(4):495-503. Pubmedid: 27180128. Pmcid: PMC7771533.
    • Grossmann P, Stringfield O, El-Hachem N, Bui MM, Rios Velazquez E, Parmar C, Leijenaar RT, Haibe-Kains B, Lambin P, Gillies R, Aerts HJ. Defining the biological basis of radiomic phenotypes in lung cancer. Elife. 2017 Jul.6. Pubmedid: 28731408. Pmcid: PMC5590809.
    • Liu Y, Bui MM, Xu B. Urothelial Carcinoma With Squamous Differentiation Is Associated With High Tumor Stage and Pelvic Lymph-Node Metastasis. Cancer Control. 2017 Jan.24(1):78-82. Pubmedid: 28178718.
    • Ding Y, Gibbs J, Xiong G, Guo S, Raj S, Bui MM. Endometriosis Mimicking Soft-Tissue Neoplasms: A Potential Diagnostic Pitfall. Cancer Control. 2017 Jan.24(1):83-88. Pubmedid: 28178719.
    • Wei S, Henderson-Jackson E, Qian X, Bui MM. Soft Tissue Tumor Immunohistochemistry Update: Illustrative Examples of Diagnostic Pearls to Avoid Pitfalls. Arch Pathol Lab Med. 2017 Aug.141(8):1072-1091. Pubmedid: 28745570. Pmcid: PMC7864385.
    • Hoggard TM, Henderson-Jackson E, Bui MM, Caracciolo J, Teer JK, Yoder S, Binitie O, Gonzalez RJ, Brohl AS, Reed DR. Myoepithelial carcinoma with RB1 mutation: remarkable chemosensitivity to carcinoma of unknown origin therapy. BMC Cancer. 2017 Apr.17(1):250. Pubmedid: 28390395. Pmcid: PMC5385017.
    • Gibbs J, Henderson-Jackson E, Bui MM. Bone and Soft Tissue Pathology: Diagnostic and Prognostic Implications. Surg Clin N Am. 2016 Oct.96(5):915-962. Pubmedid: 27542635.
    • Lloyd MC, Cunningham JJ, Bui MM, Gillies RJ, Brown JS, Gatenby RA. Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces. Cancer Res. 2016 Jun.76(11):3136-3144. Pubmedid: 27009166. Pmcid: PMC5384728.
    • Lloyd MC, Monaco JP, Bui MM. Image Analysis in Surgical Pathology. Surg Pathol Clin. 2016 Jun.9(2):329-337. Pubmedid: 27241112. Pmcid: PMC7771535.
    • von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Conrad EU, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Ne. 2016 Jun.14(6):758-786. Pubmedid: 27283169.
    • Zheng SD, Bui K, Chiappori A, Bepler G, Bui MM. RRM1, ERCC1 and TS1 Immunofluorescence Expression in Leiomyosarcoma: A Tissue Microarray Study with Clinical Outcome Correlation Analysis. Pathol Oncol Res. 2016 Jul.22(3):477-482. Pubmedid: 26612755. Pmcid: PMC6863146.
    • Pham V, Henderson-Jackson E, Doepker MP, Caracciolo JT, Gonzalez RJ, Druta M, Ding Y, Bui MM. Practical Issues for Retroperitoneal Sarcoma. Cancer Control. 2016 Jul.23(3):249-264. Pubmedid: 27556665.
    • Yin F, Han G, Bui MM, Gibbs J, Martin I, Sundharkrishnan L, King L, Jabcuga C, Stuart LN, Hassell LA. Educational Value of Digital Whole Slides Accompanying Published Online Pathology Journal Articles: A Multi-Institutional Study. Arch Pathol Lab Med. 2016 Jul.140(7):694-697. Pubmedid: 27116087.
    • Lloyd MC, Johnson JO, Kasprzak A, Bui MM. Image Analysis of the Tumor Microenvironment. Adv Exp Med Biol. 2016 Jan.936:1-10. Pubmedid: 27739040.
    • Xu H, Seifert RP, Niu X, Li Y, Bui MM. The Establishment and Utility of a Free Online Database of Primary Bone Tumors. Pathol Oncol Res. 2016 Jan.22(1):129-133. Pubmedid: 26377426.
    • Markow M, Bui MM, Lin HY, Lloyd M, Sexton WJ, Dhillon J. Evaluation of PAX8 Expression and Its Potential Diagnostic and Prognostic Value in Renal and Extra-Renal Ewing Sarcomas/PNETs. Pathol Oncol Res. 2016 Jan.22(1):115-120. Pubmedid: 26350056.
    • Raj S, Bui MM, Springett G, Conley A, Lavilla-Alonso S, Zhao X, Chen D, Haysek R, Gonzalez R, Letson GD, Finkelstein SE, Chiappori AA, Gabrilovitch DI, Antonia SJ. Long-Term Clinical Responses of Neoadjuvant Dendritic Cell Infusions and Radiation in Soft Tissue Sarcoma. Sarcoma. 2016 Feb.2015:614736. Pubmedid: 26880867. Pmcid: PMC4735941.
    • Tafreshi NK, Lloyd MC, Proemsey JB, Bui MM, Kim J, Gillies RJ, Morse DL. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia. Mol Imaging Biol. 2016 Apr.18(2):219-231. Pubmedid: 26276155. Pmcid: PMC4754166.
    • Rejniak KA, Lloyd MC, Reed DR, Bui MM. Diagnostic assessment of osteosarcoma chemoresistance based on Virtual Clinical Trials. Med Hypotheses. 2015 Sep.85(3):348-354. Pubmedid: 26130106. Pmcid: PMC4549200.
    • Niu X, Xu H, Inwards CY, Li Y, Ding Y, Letson GD, Bui MM. Primary Bone Tumors: Epidemiologic Comparison of 9200 Patients Treated at Beijing Ji Shui Tan Hospital, Beijing, China, With 10 165 Patients at Mayo Clinic, Rochester, Minnesota. Arch Pathol Lab Med. 2015 Sep.139(9):1149-1155. Pubmedid: 25978765.
    • DeVito N, Henderson E, Han G, Reed D, Bui MM, Lavey R, Robinson L, Zager JS, Gonzalez RJ, Sondak VK, Letson GD, Conley A. Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience. PLoS One. 2015 Oct.10(10):e0140362. Pubmedid: 26469269. Pmcid: PMC4607370.
    • Swalchick W, Shamekh R, Bui MM. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?. Cancer Control. 2015 Oct.22(4):498-504. Pubmedid: 26678977.
    • Richards EJ, Zhang G, Li ZP, Permuth-Wey J, Challa S, Li Y, Kong W, Dan S, Bui M, Coppola D, Mao WM, Sellers TA, Cheng JQ. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia. J Biol Chem. 2015 Mar.290(11):6857-6867. Pubmedid: 25605728. Pmcid: PMC4358111.
    • Poletto D, Bui M, Caracciolo JT. Lateral leg pain. Skeletal Radiol. 2015 Mar.44(3):463-464. Pubmedid: 25398361.
    • Poletto D, Bui M, Caracciolo JT. Test yourself: question - lateral leg pain. Skeletal Radiol. 2015 Mar.44(3):431, 463-431, 464. Pubmedid: 25391416.
    • Lloyd MC, Rejniak KA, Brown JS, Gatenby RA, Minor ES, Bui MM. Pathology to enhance precision medicine in oncology: lessons from landscape ecology. Adv Anat Pathol. 2015 Jul.22(4):267-272. Pubmedid: 26050264. Pmcid: PMC4729443.
    • Jones DH, Caracciolo JT, Hodul PJ, Strosberg JR, Coppola D, Bui MM. Familial gastrointestinal stromal tumor syndrome: report of 2 cases with KIT exon 11 mutation. Cancer Control. 2015 Jan.22(1):102-108. Pubmedid: 25504284.
    • Dodd LG, Sara Jiang X, Rao K, Bui MM. Pleomorphic liposarcoma: A cytologic study of five cases. Diagn Cytopathol. 2015 Feb.43(2):138-143. Pubmedid: 24652822.
    • Damaghi M, Tafreshi NK, Lloyd MC, Sprung R, Estrella V, Wojtkowiak JW, Morse DL, Koomen JM, Bui MM, Gatenby RA, Gillies RJ. Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane. Nat Commun. 2015 Dec.6:8752. Pubmedid: 26658462. Pmcid: PMC4682176.
    • Rosa M, Han HS, Ismail-Khan R, Allam-Nandyala P, Bui MM. Beta-catenin expression patterns in matched pre- and post-neoadjuvant chemotherapy-resistant breast cancer. Ann Clin Lab Sci. 2015 Dec.45(1):10-16. Pubmedid: 25696004.
    • Bui M, Pham V. Review of Developing and Organizing an Institutional Biospecimen Repository, edited by Donna E. Hansel and Scott D. Jewell. Biopreserv Biobank. 2015 Aug.13(4):303. Pubmedid: 26280506.
    • Ahmed AA, Abedalthagafi M, Anwar AE, Bui MM. Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic Significance. J Cancer. 2015 Aug.6(10):1005-1010. Pubmedid: 26366214. Pmcid: PMC4565850.
    • Rosa M, Abdelbaqi M, Bui KM, Nasir A, Bui MM, Shibata D, Coppola D. Overexpression of Vascular Endothelial Growth Factor A in Invasive Micropapillary Colorectal Carcinoma. Cancer Control. 2015 Apr.22(2):206-210. Pubmedid: 26068766.
    • Zia H, Murray GI, Vyhlidal CA, Leeder JS, Anwar AE, Bui MM, Ahmed AA. CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation. Int J Exp Pathol. 2015 Apr.96(2):81-86. Pubmedid: 25670065. Pmcid: PMC4459799.
    • Henderson-Jackson EB, Bui MM. Molecular Pathology of Soft-Tissue Neoplasms and Its Role in Clinical Practice. Cancer Control. 2015 Apr.22(2):186-192. Pubmedid: 26068763.
    • Jiang XS, Pantanowitz L, Bui MM, Esther R, Budwit D, Dodd LG. Clear cell chondrosarcoma: Cytologic findings in six cases. Diagn Cytopathol. 2014 Sep.42(9):784-791. Pubmedid: 24167115.
    • Zhao Y, Bui MM, Spiess PE, Dhillon J. Sclerosing PEComa of the kidney: clinicopathologic analysis of 2 cases and review of the literature. Clin Genitourin Cancer. 2014 Oct.12(5):e229-e232. Pubmedid: 25044147.
    • You Y, Shao H, Bui K, Bui M, Klapman J, Cui Q, Coppola D. Epstein-Barr virus positive inflammatory pseudotumor of the liver: report of a challenging case and review of the literature. Ann Clin Lab Sci. 2014 Nov.44(4):489-498. Pubmedid: 25361938.
    • Shi X, Chang X, Wu H, Ren X, Liu T, Bui MM. Co-existing adenoid cystic carcinoma and invasive squamous cell carcinoma of the uterine cervix: a rare case report and literature review. Ann Clin Lab Sci. 2014 Nov.44(4):502-507. Pubmedid: 25361940.
    • Tafreshi NK, Lloyd MC, Bui MM, Gillies RJ, Morse DL. Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases. Subcell Biochem. 2014 May.75:221-254. Pubmedid: 24146382. Pmcid: PMC4282494.
    • Haddox CL, Han G, Anijar L, Binitie O, Letson GD, Bui MM, Reed DR. Osteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcome. Sarcoma. 2014 Jun.2014:402509. Pubmedid: 24976784. Pmcid: PMC4021746.
    • von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU, DeLaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Van Tine BA, Wayne JD, Bergman MA, Sundar H. Gastrointestinal stromal tumors, version 2.2014. J Natl Compr Canc Ne. 2014 Jun.12(6):853-862. Pubmedid: 24925196.
    • Wu H, Zhang L, Shao H, Sokol L, Sotomayor E, Letson D, Bui MM. Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experience. Brit J Haematol. 2014 Jul.166(1):60-68. Pubmedid: 24673481.
    • You Y, Bui K, Bui MM, Malafa M, Coppola D. Histopathological and immunophenotypical features of intestinal-type adenocarcinoma of the gallbladder and its precursors. Cancer Control. 2014 Jul.21(3):247-250. Pubmedid: 24955710.
    • Rusthoven CG, Liu AK, Bui MM, Schefter TE, Elias AD, Lu X, Gonzalez RJ. Sarcomas of the aorta: a systematic review and pooled analysis of published reports. Ann Vasc Surg. 2014 Feb.28(2):515-525. Pubmedid: 24485779.
    • Wu H, Bui MM, Leston DG, Shao H, Sokol L, Sotomayor EM, Zhang L. Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas. BMC Cancer. 2014 Dec.14:900. Pubmedid: 25465716. Pmcid: PMC4265495.
    • Seifert RP, Bulkeley W, Zhang L, Menes M, Bui MM. A practical approach to diagnose soft tissue myeloid sarcoma preceding or coinciding with acute myeloid leukemia. Ann Diagn Pathol. 2014 Aug.18(4):253-260. Pubmedid: 24969631.
    • von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU, Delaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Van Tine BA, Wayne JD, Bergman MA, Sundar H. Soft tissue sarcoma, version 2.2014. J Natl Compr Canc Ne. 2014 Apr.12(4):473-483. Pubmedid: 24717567.
    • Lloyd MC, Alfarouk KO, Verduzco D, Bui MM, Gillies RJ, Ibrahim ME, Brown JS, Gatenby RA. Vascular measurements correlate with estrogen receptor status. BMC Cancer. 2014 Apr.14:279. Pubmedid: 24755315. Pmcid: PMC4012762.
    • Ding Y, Griffin JE, Raghavan M, Xu H, Henderson-Jackson E, Bui MM. Tenosynovial giant cell tumors lacking giant cells: report of diagnostic pitfalls. Ann Clin Lab Sci. 2014 Apr.44(2):222-227. Pubmedid: 24795064.
    • Bui MM, Myers C. Book Review: So You're Going to Collect a Blood Specimen. Ann Clin Lab Sci. 2014.44(1):109.
    • Kreahling JM, Foroutan P, Reed D, Martinez G, Razabdouski T, Bui MM, Raghavan M, Letson D, Gillies RJ, Altiok S. Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas. PLoS One. 2013 Sep.8(3):e57523. Pubmedid: 23520471. Pmcid: PMC3592874.
    • Deneve JL, Messina JL, Bui MM, Marzban SS, Letson GD, Cheong D, Gonzalez RJ, Sondak VK, Zager JS. Cutaneous leiomyosarcoma: treatment and outcomes with a standardized margin of resection. Cancer Control. 2013 Oct.20(4):307-312. Pubmedid: 24077407. Pmcid: PMC4504421.
    • Perez MC, Padhya TA, Messina JL, Jackson RS, Gonzalez RJ, Bui MM, Letson GD, Cruse CW, Lavey RS, Cheong D, Forster MR, Fulp WJ, Sondak VK, Zager JS. Cutaneous angiosarcoma: a single-institution experience. Ann Surg Oncol. 2013 Oct.20(11):3391-3397. Pubmedid: 23835652. Pmcid: PMC4509495.
    • Cubitt CL, Menth J, Dawson J, Martinez GV, Foroutan P, Morse DL, Bui MM, Letson GD, Sullivan DM, Reed DR. Rapid screening of novel agents for combination therapy in sarcomas. Sarcoma. 2013 Nov.2013:365723. Pubmedid: 24282374. Pmcid: PMC3824404.
    • Soliman H, Rawal B, Fulp J, Lee JH, Lopez A, Bui MM, Khalil F, Antonia S, Yfantis HG, Lee DH, Dorsey TH, Ambs S. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunol Immun. 2013 May.62(5):829-837. Pubmedid: 23344392. Pmcid: PMC4501769.
    • Demicco EG, Wang WL, Madewell JE, Huang D, Bui MM, Bridge JA, Meis JM. Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone. Am J Surg Pathol. 2013 May.37(5):752-762. Pubmedid: 23588370.
    • Fu W, Sharma SS, Ma L, Chu B, Bui MM, Reed D, Pledger WJ. Apoptosis of osteosarcoma cultures by the combination of the cyclin-dependent kinase inhibitor SCH727965 and a heat shock protein 90 inhibitor. Cell Death Dis. 2013 Mar.4:e566. Pubmedid: 23538447. Pmcid: PMC3613821.
    • Vohra NA, Turaga KK, Gonzalez RJ, Conley A, Reed D, Bui MM, Cheong D, Letson DG, Zager JS. The use of isolated limb infusion in limb threatening extremity sarcomas. Int J Hyperthermia. 2013 Jun.29(1):1-7. Pubmedid: 23205633. Pmcid: PMC4509503.
    • Koohbanani B, Han G, Reed D, Zhao Q, Yi D, Henderson-Jackson E, Bui MM. Ethnicity and age disparities in Ewing sarcoma outcome. Fetal Pediatr Pathol. 2013 Jul.32(4):246-252. Pubmedid: 23043418.
    • Riddle ND, Bui MM. Fibrous dysplasia. Arch Pathol Lab Med. 2013 Jan.137(1):134-138. Pubmedid: 23276185.
    • Allam-Nandyala P, Bui MM, Deconti R, Purohit C, Altiok S. Squamous cell carcinoma with rhabdoid phenotype of skin/soft tissue in a transplant patient: An exceptional case and review of the literature. Diagn Cytopathol. 2013 Feb.41(2):159-163. Pubmedid: 23335454.
    • Liu W, Bui MM, Cheong D, Caracciolo JT. Hibernoma: comparing imaging appearance with more commonly encountered benign or low-grade lipomatous neoplasms. Skeletal Radiol. 2013 Aug.42(8):1073-1078. Pubmedid: 23385517.
    • House JC, Henderson-Jackson EB, Johnson JO, Lloyd MC, Dhillon J, Ahmad N, Hakam A, Khalbuss WE, Leon ME, Chhieng D, Zhang X, Centeno BA, Bui MM. Diagnostic digital cytopathology: Are we ready yet?. J Pathol Inform. 2013.4:28. Pubmedid: 24392242. Pmcid: PMC3869956.
    • Bui M, Stephenson C. Laboratory administration for pathologists. Ann Clin Lab Sci. 2013.43(4):464. Pubmedid: 24247808.
    • Bui MM, Stephenson CL. What is new in the evaluation of diagnostic digital cytopathology in cervicovaginal smears?. J Pathol Inform. 2013.4(1):18. Pubmedid: 23967386. Pmcid: PMC3746412.
    • Seifert RP, McNab P, Sexton WJ, Sawczyn KK, Smith P, Coppola D, Bui MM. Rhabdomyomatous differentiation in Wilms tumor pulmonary metastases: a case report and literature review. Ann Clin Lab Sci. 2012 Oct.42(4):409-416. Pubmedid: 23090738.
    • Bai Y, Li J, Fang B, Edwards A, Zhang G, Bui M, Eschrich S, Altiok S, Koomen J, Haura EB. Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res. 2012 May.72(10):2501-2511. Pubmedid: 22461510. Pmcid: PMC4641440.
    • Riddle ND, Bui MM. When melanoma is negative for S100: diagnostic pitfalls. Arch Pathol Lab Med. 2012 Mar.136(3):237-239. Pubmedid: 22372898.
    • Tafreshi NK, Bui MM, Bishop K, Lloyd MC, Enkemann SA, Lopez AS, Abrahams D, Carter WB, Vagner J, Gobmyer SR, Gillies RJ, Morse DL. Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes. Clin Cancer Res. 2012 Jan.18(1):207-219. Pubmedid: 22016510. Pmcid: PMC4130557.
    • Kreahling JM, Gemmer JY, Reed D, Letson D, Bui M, Altiok S. MK1775, a selective Wee1 inhibitor, shows single-agent antitumor activity against sarcoma cells. Mol Cancer Ther. 2012 Jan.11(1):174-182. Pubmedid: 22084170. Pmcid: PMC4545500.
    • Finkelstein SE, Iclozan C, Bui MM, Cotter MJ, Ramakrishnan R, Ahmed J, Noyes DR, Cheong D, Gonzalez RJ, Heysek RV, Berman C, Lenox BC, Janssen W, Zager JS, Sondak VK, Letson GD, Antonia SJ, Gabrilovich DI. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients. Int J Radiat Oncol Biol Phys. 2012 Feb.82(2):924-932. Pubmedid: 21398051. Pmcid: PMC4241354.
    • Ibrahim-Hashim A, Cornnell HH, Abrahams D, Lloyd M, Bui M, Gillies RJ, Gatenby RA. Systemic buffers inhibit carcinogenesis in TRAMP mice. J Urol. 2012 Aug.188(2):624-631. Pubmedid: 22704445. Pmcid: PMC3694604.
    • von Mehren M, Benjamin RS, Bui MM, Casper ES, Conrad EU, Delaney TF, Ganjoo KN, George S, Gonzalez R, Heslin MJ, Kane JM, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Paz B, Pfeifer JD, Pollock RE, Randall RL, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Shankar S, Van Tine BA, Wayne J, Sundar H, McMillian NR. Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Ne. 2012 Aug.10(8):951-960. Pubmedid: 22878820.
    • Bardhan P, Bui MM, Minton S, Loftus L, Carter WB, Laronga C, Ismail-Khan R. HER2-positive male breast cancer with thyroid cancer: an institutional report and review of literature. Ann Clin Lab Sci. 2012.42(2):135-139. Pubmedid: 22585608.
    • Henderson-Jackson E, Sexton W, Zhang J, Hakam A, Petrovskyy VS, Bui MM, Chuang ST. Cystic prostatic ductal adenocarcinoma: an unusual presentation and cytological diagnosis. Ann Clin Lab Sci. 2012.42(1):81-88. Pubmedid: 22371914.
    • Nasir A, Helm J, Turner L, Chen DT, Strosberg J, Hafez N, Henderson-Jackson EB, Hodul P, Bui MM, Nasir NA, Hakam A, Malafa MP, Yeatman TJ, Coppola D, Kvols LK. RUNX1T1: a novel predictor of liver metastasis in primary pancreatic endocrine neoplasms. Pancreas. 2011 May.40(4):627-633. Pubmedid: 21499216. Pmcid: PMC4732279.
    • Zhang X, Bui MM, Caracciolo J, Field TL, Zhang L. Adult anaplastic large cell lymphoma involving the central nervous system: a rare clinical scenario. Ann Hematol. 2011 Jun.90(6):721-723. Pubmedid: 20838823.
    • Fu W, Ma L, Chu B, Wang X, Bui MM, Gemmer J, Altiok S, Pledger WJ. The cyclin-dependent kinase inhibitor SCH 727965 (dinacliclib) induces the apoptosis of osteosarcoma cells. Mol Cancer Ther. 2011 Jun.10(6):1018-1027. Pubmedid: 21490307. Pmcid: PMC4727401.
    • Bui MM, Han G, Acs G, Reed D, Gonzalez RJ, Pasha TL, Zhang PJ. Connexin 43 is a potential prognostic biomarker for ewing sarcoma/primitive neuroectodermal tumor. Sarcoma. 2011 Jul.2011:971050. Pubmedid: 21647307. Pmcid: PMC3103998.
    • Riddle ND, Quigley BC, Browarsky I, Bui MM. Leiomyosarcoma arising in the pancreatic duct: a case report and review of the current literature. Case Rep Med. 2011 Jul.2010:252364. Pubmedid: 20589089. Pmcid: PMC2892659.
    • Riddle ND, Gonzalez RJ, Bridge JA, Antonia S, Bui MM. A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: diagnostic pitfalls of ancillary studies in sarcoma. Cancer Control. 2011 Jul.18(3):152-159. Pubmedid: 21666577.
    • Shackelford RE, Allam-Nandyala P, Bui MM, Kiluk JV, Esposito NN. Primary colorectal adenocarcinoma metastatic to the breast: case report and review of nineteen cases. Case Rep Med. 2011 Jul.2011:738413. Pubmedid: 21738536. Pmcid: PMC3123911.
    • Tafreshi NK, Enkemann SA, Bui MM, Lloyd MC, Abrahams D, Huynh AS, Kim J, Grobmyer SR, Carter WB, Vagner J, Gillies RJ, Morse DL. A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes. Cancer Res. 2011 Feb.71(3):1050-1059. Pubmedid: 21169406. Pmcid: PMC4130564.
    • Bui MM, Purohit CN, Hakam A. Fine needle aspiration biopsy of an osteoclast-rich undifferentiated urothelial carcinoma: A cytology case report and review of the literature. Cytojournal. 2010 Sep.7:18. Pubmedid: 20976205. Pmcid: PMC2955341.
    • Henderson-Jackson EB, Helm J, Ghayouri M, Hakam A, Nasir A, Leon M, Bui M, Yeatman T, Coppola D. Correlation between Mcl-1 and pAKT protein expression in colorectal cancer. Int J Clin Exp Pathol. 2010 Oct.3(8):768-774. Pubmedid: 21151390. Pmcid: PMC2993227.
    • Naghashpour M, Cualing HD, Szabunio M, Bui MM. Hyaline-vascular castleman disease: a rare cause of solitary subcutaneous soft tissue mass. Am J Dermatopathxxx. 2010 May.32(3):293-297. Pubmedid: 20098298.
    • Shackelford RE, Bui MM, Coppola D, Hakam A. Over-expression of nicotinamide phosphoribosyltransferase in ovarian cancers. Int J Clin Exp Pathol. 2010 Jun.3(5):522-527. Pubmedid: 20606733. Pmcid: PMC2897104.
    • Demetri GD, Antonia S, Benjamin RS, Bui MM, Casper ES, Conrad EU, DeLaney TF, Ganjoo KN, Heslin MJ, Hutchinson RJ, Kane JM, Letson GD, McGarry SV, O'Donnell RJ, Paz IB, Pfeifer JD, Pollock RE, Randall RL, Riedel RF, Schupak KD, Schwartz HS, Thornton K, von Mehren M, Wayne J. Soft tissue sarcoma. J Natl Compr Canc Ne. 2010 Jun.8(6):630-674. Pubmedid: 20581298.
    • Ismail-Khan R, Bui MM. A review of triple-negative breast cancer. Cancer Control. 2010 Jul.17(3):173-176. Pubmedid: 20664514.
    • Rusthoven C, Shames ML, Bui MM, Gonzalez RJ. High-grade undifferentiated pleomorphic sarcoma of the aortic arch: a case of endovascular therapy for embolic prophylaxis and review of the literature. Vasc Endovascular Surg. 2010 Jul.44(5):385-391. Pubmedid: 20538733.
    • Bui MM, Draper NL, Dessureault S, Nasir NA, Cooper H, Nasir A, Coppola D. Colonic angiolymphoid hyperplasia with eosinophilia masquerading as malignancy: a case report and review of the literature. Clin Colorectal Cancer. 2010 Jul.9(3):179-182. Pubmedid: 20643624.
    • Allam-Nandyala P, Bui MM, Caracciolo JT, Hakam A. Squamous cell carcinoma and osteosarcoma arising from a dermoid cyst--a case report and review of literature. Int J Clin Exp Pathol. 2010 Jan.3(3):313-318. Pubmedid: 20224730. Pmcid: PMC2836509.
    • Moody P, Bui MM, Vrionis F, Setzer M, Rojiani AM. Synovial chondromatosis of spine: case report and review of the literature. Ann Clin Lab Sci. 2010 Feb.40(1):71-74. Pubmedid: 20124333.
    • Riddle ND, Yamauchi H, Caracciolo JT, Cheong D, Khakpour N, Bui MM. Giant cell tumor of the anterior rib masquerading as a breast mass: a case report and review of current literature. Cases J. 2010 Feb.3:51. Pubmedid: 20205847. Pmcid: PMC2825505.
    • Lloyd MC, Allam-Nandyala P, Purohit CN, Burke N, Coppola D, Bui MM. Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: How reliable is it?. J Pathol Inform. 2010 Dec.1:29. Pubmedid: 21221174. Pmcid: PMC3017682.
    • Chen Y, Gruidl M, Remily-Wood E, Liu RZ, Eschrich S, Lloyd M, Nasir A, Bui MM, Huang E, Shibata D, Yeatman T, Koomen JM. Quantification of beta-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry. J Proteome Res. 2010 Aug.9(8):4215-4227. Pubmedid: 20590165. Pmcid: PMC2924816.
    • Farma JM, Ammori JB, Zager JS, Marzban SS, Bui MM, Bichakjian CK, Johnson TM, Lowe L, Sabel MS, Wong SL, Letson GD, Messina JL, Cimmino VM, Sondak VK. Dermatofibrosarcoma protuberans: how wide should we resect?. Ann Surg Oncol. 2010 Aug.17(8):2112-2118. Pubmedid: 20354798.
    • Bui MM, Zheng Z, Antonia S, Bepler G. Thymidylate synthase 1 (TS1) in-situ protein expression predicts the survival of Ewing/PNET. Fetal Pediatr Pathol. 2010.29(6):385-392. Pubmedid: 21043562. Pmcid: PMC3568950.
    • Schlauder SM, Knapp C, Steffensen TS, Bui MM. Aromatase may play a critical role in the pathogenesis of juvenile nasopharyngeal angiofibroma. Fetal Pediatr Pathol. 2009 Oct.28(5):232-238. Pubmedid: 19842877.
    • Yasuda T, Perry KD, Nelson M, Bui MM, Nasir A, Goldschmidt R, Gnepp DR, Bridge JA. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Hum Pathol. 2009 Mar.40(3):341-348. Pubmedid: 18973919. Pmcid: PMC2753286.
    • McNab PM, DeMers NM, Schlauder S, Morgan M, Nasir A, Coppola D, Bui MM. Potential utility of CD5 immunohistochemical staining in the diagnosis of muscle tumors. Ann Clin Lab Sci. 2009 Jul.39(2):108-113. Pubmedid: 19429795.
    • DeMers Riddle NM, Schlauder SM, Bui MM. Immunostain patterns of HER-2, EGFR, and CD117 in fibrous dysplasia: a six case series and literature review. J Orthop. 2009 Jan.6(2):e4.
    • Alexander GE, Henderson ER, Rodriguez AR, Bui MM, Cheong D, Letson GD. Extraskeletal myxoid chondrosarcoma: rare presentation in the knee joint space. Orthopedics. 2009 Dec.32(12):919. Pubmedid: 19968226.
    • Riddle ND, Bowers JW, Bui MM, Morgan MB. Primary cutaneous osteoblastic osteosarcoma: a case report and review of the current literature. Clin Exp Dermatol. 2009 Dec.34(8):e879-e880. Pubmedid: 20055854.
    • Zager J, Bui M, Farma J, Messina J, Sondak V. Proper margins of excision in dermatofibrosarcoma protuberans: wide or narrow?. Ann Surg Oncol. 2008 Sep.15(9):2614-2616. Pubmedid: 18452044.
    • Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, Nacken W, Sorg C, Vogl T, Roth J, Gabrilovich DI. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med. 2008 Sep.205(10):2235-2249. Pubmedid: 18809714. Pmcid: PMC2556797.
    • Bui M, Smith P, Agresta S, Cheong D, Letson G. Practical issues of intraoperative frozen section diagnosis of bone and soft tissue lesions. Cancer Control. 2008 Jan.15(1):7-12. Pubmedid: 18094656.
    • Steffensen T, Gilbert-Barness E, Wagoner M, Bui M, Browarsky I. Human chorionic gonadotrophin producing epithelioid sarcoma metastatic to the placenta. Fetal Pediatr Pathol. 2008 Jan.27(6):282-291. Pubmedid: 19065326.
    • Draper N, Bui M, Boulware DC, Lloyd M, Chiappori AA, Pledger WJ, Coppola D. Increased cyclin D3 expression significantly correlates with p27 nuclear positivity in gastrointestinal stromal tumors. Hum Pathol. 2008 Dec.39(12):1784-1791. Pubmedid: 18701138.
    • Schlauder SM, Steffensen TS, Morgan M, Letson DG, Pledger WJ, Ma L, Bui MM. Assessment of muscarinic and nicotinic acetylcholine receptor expression in primitive neuroectodermal tumor/ewing family of tumor and desmoplastic small round cell tumor: an immunohistochemical and Western blot study of tissue microarray and cell lines. Fetal Pediatr Pathol. 2008 Aug.27(2):83-97. Pubmedid: 18568996.
    • Bui MM, Bagui TK, Boulware DC, Letson DG, Nasir A, Kaiser HE, Pledger WJ, Coppola D. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms. In Vivo. 2007 Sep.21(5):729-737. Pubmedid: 18019405.
    • Dorfman DM, Bui MM, Tubbs RR, Hsi ED, Fitzgibbons PL, Linden MD, Rickert RR, Roche PC. The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee Study. Arch Pathol Lab Med. 2006 Jun.130(6):779-782. Pubmedid: 16740027.
    • Khalbuss W, Bui M, Loya A. A 19-year-old woman with a cervicovaginal mass and elevated serum CA 125. Desmoplastic small round cell tumor. Arch Pathol Lab Med. 2006 Apr.130(4):e59-e61. Pubmedid: 16594762.
    • Bui M, Khalbuss WE. Primary small cell neuroendocrine carcinoma of the urinary bladder with coexisting high-grade urothelial carcinoma: a case report and a review of the literature. Cytojournal. 2005 Nov.2:18. Pubmedid: 16269089. Pmcid: PMC1310524.
    • Khalbuss W, Grigorian S, Bui M, Elhosseiny A. Small-cell tumors of the liver: a cytological study of 91 cases and a review of the literature. Diagn Cytopathol. 2005 Jul.33(1):8-14. Pubmedid: 15945087.
    • Masood S, Bui M. Prognostic and predictive value of HER2/neu oncogene in breast cancer. Microsc Res Tech. 2002 Oct.59(2):102-108. Pubmedid: 12373720.
    • Lu D, Masood S, Khalbuss W, Bui M. A subset of breast invasive ductal carcinoma with distinctive cytomorphology, aggressive clinical behavior, and unique immunologic profiles. Cancer. 2002 Oct.96(5):294-300. Pubmedid: 12378597.
    • Yu M, Bui M, Gulati P, Masood S. Lipogranuloma. Breast J. 2001 Sep.7(5):363-364. Pubmedid: 11906448.
    • Yu M, Bui M, Bridges M, Masood S. Papillary carcinoma. Breast J. 2001 Jan.7(1):68-69. Pubmedid: 11348420.
    • Masood S, Bui M. Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study. Ann Clin Lab Sci. 2000 Jul.30(3):259-265. Pubmedid: 10945565.
    • Amornmarn R, Bui M, Prempree T, Masood S. Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy. Ann Clin Lab Sci. 2000 Jan.30(1):33-40. Pubmedid: 10678581.
    • Persons D, Bui M, Lowery M, Mark H, Yung J, Birkmeier J, Wong E, YangSJ, Masood S. Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study. Ann Clin Lab Sci. 2000 Jan.30(1):41-48. Pubmedid: 10678582.
    • Amornmarn R, Prempree T, Bui MM, Masood S. p53 mutation and MDR1 overexpression in local and distant failures of breast cancer treated by lumpectomy and radiation. Thai J Surg. 1999 Jan.20(1):1-8.
    • Masood S, Bui M, Lu L. Comparison of proliferation activity in breast carcinoma by flow cytomet analysis of S-phase and quantitative analysis of MIB-1. Ann Clin Lab Sci. 1998 Nov.28(6):315-323. Pubmedid: 9846198 .
    • Masood S, Bui M, Yung J, Mark H, Wong E, Birkmeier J, Yang S, Hsu P. Reproducibility of LSI HER-2/neu SpectrumOrange and CEP 17 SpectrumGreen Dual Color deoxyribonucleic acid probe kit. Ann Clin Lab Sci. 1998 Jul.28(4):215-223. Pubmedid: 9715348 .
    • Masood S, Bui MM, Yung JF, Mark HF, Wong EY, Birkmeier JM, Yang SJ, Hsu P. Reproducibility of LSI HER-2/neu SpectrumOrange and CEP 17 SpectrumGreen Dual Color deoxyribonucleic acid probe kit. For enumeration of gene amplification in paraffin-embedded specimens: a multicenter clinical validation study. Ann Clin Lab Sci. 1998 Jul.28(4):215-223. Pubmedid: 9715348.
    • Masood S, Bui M, Kublius P, Slovak M. Cytogenetic abnormalities of primary breast carcinoma: comparative analysis of fluorescence in situ hybridization (FISH) and flow cytometry. Breast J. 1998.4(2):89-95. Pubmedid: NoPMID.
    • Bui M, Luo D, She J, Maclaren N, Muir A, Thomson G, She J. Paternally transmitted IDDM2 influences diabetes susceptibility despite biallelic expression of the insulin gene in human pancreas. J Autoimmun. 1996 Feb.9(1):97-103. Pubmedid: 8845059 .
    • Bui M, Jenkins S. Clinical infectious disease testing by amplification technology. Jacksonville Medicine. 1996.47(6):247-250. Pubmedid: NoPMID.
    • Luo D, Bui M, Muir A, Maclaren N, Thomson G, She J. Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet. 1995 Oct.57(4):911-919. Pubmedid: 7573053 .
    • She J, Bui M, Tian X, Muir A, Wakeland E, Zorovich B, Zhang L, Liu M, Thomson G, Maclaren N. Additive susceptibility to insulin-dependent diabetes conferred by HLA-DQB1 and insulin genes. Autoimmunity. 1994.18(3):195-203. Pubmedid: 7858104 .
  • Grants

    Title: Automated De-Identification of Pathology and Radiology Data
    Sponsor: Nat Institutes of Health
    PI: Rasool, G., CO-PI: Folio, L., CO-PI: Bui, M., CO-PI: Farinhas, J.
  • Patient Comments

    Overall Satisfaction


    0 patients rated this provider

    The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

    Learn more about our patient satisfaction survey



    Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

    We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

    Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

    Learn more about our patient comments

    Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

    • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
    • He or she may be a researcher or other type of provider that does not see patients.
    • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.

    Learn more about our patient satisfaction survey, ratings and comments

Find a Doctor